Indication
LACRISERT^® (hydroxypropyl cellulose ophthalmic insert) is indicated in patients with moderate to severe Dry Eye Syndromes, including keratoconjunctivitis sicca. LACRISERT^® is indicated especially in patients who remain symptomatic after an adequate trial of therapy with artificial tear solutions. LACRISERT^® is also indicated for patients with exposure keratitis, decreased corneal sensitivity, and recurrent corneal erosions.

Important Safety Information

LACRISERT^® is contraindicated in patients who are hypersensitive to hydroxypropyl cellulose. Instructions for inserting and removing LACRISERT^® should be carefully followed. If improperly placed, LACRISERT^® may result in corneal abrasion. Because LACRISERT^® may cause transient blurred vision, patients should be instructed to exercise caution when driving or operating machinery. The patient should be cautioned against rubbing the eye(s) containing LACRISERT^®. The following adverse reactions have been reported, but were in most instances, mild and temporary: transient blurring of vision, ocular discomfort or irritation, matting or stickiness of eyelashes, photophobia, hypersensitivity, eyelid edema, and hyperemia.

Click here for full Prescribing Information

Sponsored by

© 2013 Valeant Ophthalmics, a division of Valeant Pharmaceuticals North America LLC Bridgewater, NJ 08807     | LAC122-1112